pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
ML-061
Docivyx (docetaxel)
Adenocarcinoma Of The Gastroesophageal Junction
Meridian Laboratories Inc
0
catalysts
Preclinical
MLN-33
Melanoma
$CNBX
CNBX Pharmaceuticals Inc.
0
catalysts
Phase 1
MO-03
Metastatic Renal Cell Carcinoma
Osel Inc
0
catalysts
Phase 1
← prev
page 27 of 62
next →
131
Pain
89
Neurology
1
MOMA-313
Metastatic Breast Cancer
Moma Therapeutics Inc
0
catalysts
Preclinical
MOMA-989
Unspecified Cancer
Moma Therapeutics Inc
0
catalysts
Phase 2
MP-0712
Neuroendocrine Tumors
$MOLN
MOLECULAR PARTNERS AG
0
catalysts
Phase 2
MPB-1734
Solid Tumor
MegaPro Biomedical Co Ltd
0
catalysts
Phase 2
MRG-002
Gastric Cancer
Shanghai Miracogen Inc
0
catalysts
Phase 2
MRG-004A
Solid Tumor
Shanghai Miracogen Inc
0
catalysts
Phase 2
MRT-2359
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$GLUE
Monte Rosa Therapeutics, Inc.
0
catalysts
Phase 1
MRX-2843
Non-Small Cell Lung Cancer
Meryx Inc
0
catalysts
Phase 2
MT-125
Glioblastoma Multiforme (GBM)
Myosin Therapeutics Inc
0
catalysts
Phase 2
MTG-201
Prostate Cancer
Momotaro-Gene Inc
0
catalysts
Phase 1
MTI-201
Metastatic Uveal Melanoma
Modulation Therapeutics Inc
0
catalysts
Phase 2
MTL-CEBPA
Hepatocellular Carcinoma
Mina Therapeutics Ltd
0
catalysts
Preclinical
MVP-0601
Malignant Pleural Mesothelioma
OncoVITA SAS
0
catalysts
Phase 2
MVRT-3011
Recurrent Head And Neck Squamous Cell Carcinoma
Immvira Co Ltd
0
catalysts
Phase 2
MWTx-01
Polycythemia Vera
$IRON
Disc Medicine, Inc.
0
catalysts
Preclinical
MX-1604
Liver Cancer
Mesox Ltd
0
catalysts
Phase 2
MesoCancerVac
MesoPher
Malignant Mesothelioma
Amphera BV
0
catalysts
Marketed
Metastron
Metastron (strontium chloride sr 89)
Bone Metastasis
Q BioMed Inc
0
catalysts
Preclinical
MiNK-215
Melanoma
$INKT
MiNK Therapeutics, Inc.
0
catalysts
Phase 3
Multikine
Head And Neck Squamous Cell Carcinoma (HNSC)
CEL-SCI Corp
0
catalysts
Phase 2
NB-003
Gastrointestinal Stromal Tumor (GIST)
NewBay Medical Technology Co Ltd
0
catalysts
Phase 2
NBM-BMX
Metastatic Uveal Melanoma
Novelwise Pharmaceutical Corp
0
catalysts
Phase 2
NC-410
Cervical Cancer
$NXTC
NextCure, Inc.
0
catalysts
Preclinical
NED-170
Bile Duct Cancer (Cholangiocarcinoma)
NED Biosystems Inc
0
catalysts
Phase 2
NEO-100
Recurrent Glioblastoma Multiforme (GBM)
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
Phase 2
NEO-212
Astrocytoma
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
Preclinical
NERx-329
Lung Cancer
NERx BioSciences Inc
0
catalysts
